NovaBridge BiosciencesFRA:0VY +2.72%37 Pretax Margin % is % as of Dec. 2025. GuruFocus rates FRA:0VY with a GF Score™ of 37/100 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 938 Biotechnology companies, NovaBridge Biosciences ranks worse than 106609.7% on this metric.
The historical rank and industry rank for NovaBridge Biosciences's Pretax Margin % or its related term are showing as below:
FRA:0VY's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -89.895 * Ranked among companies with meaningful Pretax Margin % only.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
NovaBridge Biosciences Pretax Margin % Related Terms
NovaBridge Biosciences Pretax Margin % Historical Data
* Premium members only.
The historical data trend for NovaBridge Biosciences's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:0VY vs HUMA, DTIL, ORMP: Pretax Margin % Comparison
For the Biotechnology subindustry, NovaBridge Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NovaBridge Biosciences Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NovaBridge Biosciences's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where NovaBridge Biosciences's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovaBridge Biosciences (FRA:0VY) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on NovaBridge Biosciences and its competitors. According to the industry distribution chart, NovaBridge Biosciences ranks #999999 out of 938 companies in the Biotechnology industry.
Is NovaBridge Biosciences' Pretax Margin % too high?
NovaBridge Biosciences' current Pretax Margin % is %. Based on the distribution chart, NovaBridge Biosciences ranks #999999 out of 938 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, NovaBridge Biosciences has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NovaBridge Biosciences' Pretax Margin % compare to HUMA and DTIL?
According to the Biotechnology industry distribution chart, NovaBridge Biosciences ranks #999999 out of 938 companies for Pretax Margin %. This places NovaBridge Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on NovaBridge Biosciences and its competitors. NovaBridge Biosciences's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NovaBridge Biosciences stock overvalued right now?
Based on GuruFocus' analysis, NovaBridge Biosciences (FRA:0VY) is currently considered Possible Value Trap. The current Pretax Margin % is %. NovaBridge Biosciences' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For NovaBridge Biosciences (FRA:0VY), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
37GF Score
Get the complete analysis for FRA:0VY
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:0VY has been successfully added to your 
